3CLpro-1
3CLpro-1是一种与芦平曲韦相关的抗病毒药物,作为3C样蛋白酶抑制剂,最初开发用于治疗人类肠病毒71型。它是作为病毒酶3C样蛋白酶抑制剂开发的众多化合物中最有效的一种蛋白酶,体外IC50为200nM。它还显示出对SARS和MERS等冠状病毒疾病的活性,并且正在研究作为病毒性疾病COVID-19的潜在治疗剂。病毒性疾病COVID-19的治疗剂。[1][2][3][4][5][6][7]
臨床資料 | |
---|---|
商品名 | 3CLpro-1 |
法律規範狀態 | |
法律規範 |
|
识别 | |
| |
CAS号 | 2409054-43-7 |
PubChem CID | |
ChemSpider | |
ChEMBL | |
化学 | |
化学式 | C25H25ClFN3O4 |
摩尔质量 | 640.8 |
3D模型(JSmol) | |
| |
|
参考资料
- Kuo CJ, Shie JJ, Fang JM, Yen GR, Hsu JT, Liu HG, et al. . Bioorganic & Medicinal Chemistry. August 2008, 16 (15): 7388–98. PMC 7125518 . PMID 18583140. doi:10.1016/j.bmc.2008.06.015.
- Zhou Y, Vedantham P, Lu K, Agudelo J, Carrion R, Nunneley JW, et al. . Antiviral Research. April 2015, 116: 76–84. PMC 4774534 . PMID 25666761. doi:10.1016/j.antiviral.2015.01.011 .
- Kumar V, Shin JS, Shie JJ, Ku KB, Kim C, Go YY, et al. . Antiviral Research. May 2017, 141: 101–106. PMC 7113684 . PMID 28216367. doi:10.1016/j.antiviral.2017.02.007 .
- Liu C, Zhou Q, Li Y, Garner LV, Watkins SP, Carter LJ, et al. . ACS Central Science. 2020, 6 (3): 315–331. PMC 7094090 . PMID 32226821. doi:10.1021/acscentsci.0c00272 .
- Morse JS, Lalonde T, Xu S, Liu WR. . ChemBioChem. March 2020, 21 (5): 730–738. PMC 7162020 . PMID 32022370. doi:10.1002/cbic.202000047 .
- Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, et al. . Journal of Medicinal Chemistry. February 2020, 63 (9): 4562–4578. PMC 7098070 . PMID 32045235. doi:10.1021/acs.jmedchem.9b01828 .
- Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, et al. . Science. March 2020, 368 (6489): 409–412. PMC 7164518 . PMID 32198291. doi:10.1126/science.abb3405 .
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.